Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies
Clinical trial NCT03367819 · TERMINATED
Trial details
- NCT number
- NCT03367819
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-04
- Primary completion
- 2021-03-10
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.